A Multicenter, Open-Label, Pharmacokinetic and Safety Study of Baricitinib in Pediatric Patients from 1 Year to Less than 18 Years Old Hospitalized with COVID-19

Project: Research project

Project Details

StatusActive
Effective start/end date10/1/21 → 9/30/26

Funding

  • Eli Lilly: $11,560.00